EyePoint Pharmaceuticals Inc.

EYPT | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.03

+$0.01 (+0.25%)

Sep 22, 2026, 2:30 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Cash & Equivalents	110.46M	77.71M	101.82M	74.58M	71.14M	85.16M	99.7M	79.83M	90.77M	271.01M	281.26M	133.04M	139.6M	105.77M	95.63M	75.36M	82.13M	101.55M	178.59M	119.71M	127.63M	138.58M
Short-Term Investments	70.01M	144.83M	204.27M	129.45M	184.59M	233.04M	271.21M	173.96M	189.48M	28.34M	49.79M	2.98M	2.94M	16.72M	48.93M	81.9M	89.03M	89.24M	32.97M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	150K	150K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	150K	150K	150K
Other Long-Term Assets	9.52M	18.94M	15.12M	6.07M	14.81M	6.03M	5.98M	2.57M	150K	n/a	n/a	150K	150K	150K	150K	150K	150K	150K	150K	n/a	150K	150K
Receivables	86K	1.16M	651K	1.05M	625K	442K	607K	378K	1.38M	3.02M	805K	483K	10.95M	10.42M	15.5M	20.88M	22.59M	19.59M	18.35M	13.6M	15.11M	12.33M
Inventory	1.88M	1.25M	1.81M	2.11M	2.68M	2.13M	2.31M	2.81M	3.67M	4.26M	3.91M	4.58M	4.26M	4.07M	2.89M	3.53M	3.25M	3.34M	3.62M	4.57M	5.38M	5.59M
Other Current Assets	n/a	24.55M	20.11M	8.93M	6.22M	1.4M	1.41M	1.3M	1.07M	1.48M	1.01M	9.09M	9.37M	9.08M	782K	n/a	n/a	n/a	517K	n/a	3.7M	2.86M
Total Current Assets	188.82M	249.5M	328.66M	216.11M	265.25M	326.98M	383.31M	268.55M	294.93M	317.71M	344.8M	150.16M	167.12M	146.06M	172.81M	192.1M	205.87M	219.63M	237.75M	141.78M	151.83M	159.35M
Property-Plant & Equipment	29.86M	19.78M	20.22M	29.52M	21.09M	29.55M	29.18M	29.8M	29.17M	11.39M	10.23M	9.73M	8.39M	8.39M	7.4M	7.33M	5.9M	2.64M	2.73M	2.96M	2.87M	3.04M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	20.9M	21.52M	22.13M	22.75M	23.36M	23.98M	24.59M
Total Long-Term Assets	39.37M	38.71M	35.34M	35.59M	35.9M	35.58M	35.16M	32.37M	29.32M	11.54M	10.38M	9.88M	8.54M	8.54M	7.55M	28.39M	27.57M	24.93M	25.63M	26.48M	27M	27.79M
Total Assets	228.19M	288.22M	364M	251.7M	301.15M	362.56M	418.47M	300.92M	324.25M	329.25M	355.18M	160.04M	175.66M	154.59M	180.36M	220.49M	233.43M	244.56M	263.37M	168.25M	178.82M	187.14M
Account Payables	17.27M	18.81M	10.49M	10.08M	19.69M	16.42M	11.72M	7.34M	14.3M	7.08M	6.5M	9.58M	10.72M	9.45M	5.92M	6.11M	7.06M	7.3M	7.39M	6.64M	5.42M	5.86M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	5.12M	17.78M	26M	33.34M	38.38M	38.59M	39.84M	42.08M	1.24M	1.21M	1.17M	1.14M	1.1M	1.07M	1.04M	1.01M	973K
Short-Term Debt	n/a	2.08M	n/a	1.96M	n/a	n/a	n/a	n/a	n/a	1.1M	563K	n/a	n/a	5.3M	10.48M	10.48M	10.48M	10.48M	n/a	n/a	n/a	n/a
Other Current Liabilities	126K	9.88M	180K	7.13M	9.76M	5.59M	13.27M	10.2M	6.99M	10.52M	4.97M	8.47M	6.27M	5.03M	9.52M	6.55M	5.29M	3.82M	7.32M	5.31M	6.36M	3.03M
Total Current Liabilities	41.94M	37.46M	37.02M	30.09M	33.18M	41.68M	49.05M	48.79M	62.1M	62.58M	63.26M	63.9M	68.92M	27.24M	34.54M	34.26M	33.39M	31.97M	23.66M	19.93M	16.25M	13.44M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	29.37M	29.31M	29.25M	29.18M	29.11M	36.56M	36.4M	36.24M	38.12M
Other Long-Term Liabilities	23K	55K	87K	118K	148K	177K	205K	233K	n/a	n/a	20.69M	n/a	n/a	600K	600K	600K	600K	658K	2.35M	2.36M	2.33M	2.35M
Total Long-Term Liabilities	19.84M	20.28M	20.86M	21.42M	21.96M	22.49M	32.92M	33.39M	33.84M	16.73M	25.6M	37.53M	49.48M	48.96M	49.45M	49.88M	48.68M	45.77M	55.33M	55.57M	55.71M	57.99M
Total Liabilities	61.78M	57.75M	57.88M	51.51M	55.14M	64.17M	81.96M	82.18M	95.94M	79.31M	88.86M	101.42M	118.39M	76.2M	83.99M	84.14M	82.07M	77.74M	78.99M	75.5M	71.96M	71.43M
Total Debt	22.37M	22.31M	22.79M	23.26M	21.82M	24.08M	21.86M	21.92M	23.29M	5.72M	5.47M	6.24M	6.43M	40.39M	46.35M	46.46M	44.48M	41.28M	39.2M	38.42M	38.25M	40.3M
Book Value	166.41M	230.47M	306.11M	200.18M	246.01M	298.4M	336.5M	218.73M	228.31M	249.93M	266.32M	58.62M	57.26M	78.39M	96.37M	136.35M	151.37M	166.82M	184.38M	92.75M	106.87M	115.71M
Book Value Per Share	1.92	2.68	3.69	2.85	3.52	4.28	5.21	4.02	4.29	4.72	6.32	1.53	1.52	2.09	2.58	3.65	4.06	4.48	5.64	3.22	3.72	4.68
Common Stock	85K	83K	83K	70K	69K	69K	68K	53K	52K	50K	49K	35K	34K	34K	34K	34K	34K	34K	34K	29K	29K	29K
Retained Earnings	-1.28B	-1.19B	-1.1B	-1.04B	-977.64M	-918.21M	-873.02M	-831.62M	-802.26M	-771.43M	-742.15M	-728.05M	-715.44M	-692.52M	-671.35M	-627.9M	-609.48M	-590.07M	-569.1M	-549.67M	-532.97M	-522.96M
Comprehensive Income	793K	802K	961K	919K	832K	923K	1.03M	1.17M	792K	836K	864K	841K	842K	843K	786K	653K	602K	788K	841K	841K	841K	841K
Shareholders Equity	166.41M	230.47M	306.11M	200.18M	246.01M	298.4M	336.5M	218.73M	228.31M	249.93M	266.32M	58.62M	57.26M	78.39M	96.37M	136.35M	151.37M	166.82M	184.38M	92.75M	106.87M	115.71M
Total Investments	70.01M	144.83M	204.27M	129.45M	184.59M	233.04M	271.21M	173.96M	189.48M	28.49M	49.94M	2.98M	2.94M	16.72M	48.93M	81.9M	89.03M	89.24M	32.97M	150K	150K	150K